Quantitative analysis of airway obstruction in lymphangioleiomyomatosis

Eur Respir J. 2020 Jul 2;56(1):1901965. doi: 10.1183/13993003.01965-2019. Print 2020 Jul.

Abstract

Lymphangioleiomyomatosis (LAM) is a rare, cystic lung disease with progressive pulmonary function loss caused by progressively proliferating LAM cells. The degree of airway obstruction has not been well investigated within the pathogenesis of LAM.Using a combination of ex vivo computed tomography (CT), microCT and histology, the site and nature of airway obstruction in LAM explant lungs was compared with matched control lungs (n=5 each). The total number of airways per generation, total airway counts, terminal bronchioles number and surface density were compared in LAM versus control.Ex vivo CT analysis demonstrated a reduced number of airways from generation 7 on (p<0.0001) in LAM compared with control, whereas whole-lung microCT analysis confirmed the three- to four-fold reduction in the number of airways. Specimen microCT analysis further demonstrated a four-fold decrease in the number of terminal bronchioles (p=0.0079) and a decreased surface density (p=0.0079). Serial microCT and histology images directly showed the loss of functional airways by collapse of airways on the cysts and filling of the airway by exudate.LAM lungs show a three- to four-fold decrease in the number of (small) airways, caused by cystic destruction which is the likely culprit for the progressive loss of pulmonary function.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Airway Obstruction* / diagnostic imaging
  • Airway Obstruction* / etiology
  • Bronchioles
  • Humans
  • Lung / diagnostic imaging
  • Lung Neoplasms* / complications
  • Lung Neoplasms* / diagnostic imaging
  • Lymphangioleiomyomatosis* / complications
  • Lymphangioleiomyomatosis* / diagnostic imaging